Literature DB >> 18552341

In vitro antifungal drug susceptibilities of dermatophytes microconidia and arthroconidia.

Luciene M Coelho1, Roseli Aquino-Ferreira, Cláudia M Leite Maffei, Nilce M Martinez-Rossi.   

Abstract

OBJECTIVES: Arthroconidia have been considered as the primary cause of infection by dermatophytes. However, the in vitro antifungal testing evaluates the responses mainly of microconidia or hyphae, and dermatophytes in vivo often produce arthroconidia, a cellular structure presumably more resistant to antifungals. The aim of this study was to compare the in vitro susceptibility of microconidia and arthroconidia of Trichophyton rubrum, Trichophyton tonsurans and Trichophyton equinum to griseofulvin, itraconazole, terbinafine, fluconazole, amphotericin B and hygromycin B.
METHODS: Microconidia and arthroconidia were produced in vitro, and their susceptibility to each drug was evaluated by assessing the CLSI M38-A broth microdilution method.
RESULTS: Arthroconidia of all strains analysed appeared to be more resistant to fluconazole, griseofulvin and itraconazole than microconidia. The MIC of terbinafine was the same for microconidia and arthroconidia for all strains, and the MIC of amphotericin B for microconidia and arthroconidia was the same for isolates of T. equinum and T. tonsurans, but differed for T. rubrum. Finally, the level of resistance of microconidia for all strains towards the antibiotic hygromycin B was from 25 to 400 mg/L.
CONCLUSIONS: The difference in the susceptibility between microconidia and arthroconidia depends on the drug and on the strain, and may be one of the causes of therapeutic failure. Also, the level of resistance to the antibiotic hygromycin B presented by microconidia of these isolates will allow the use of hygromycin resistance as a dominant marker in fungal transformation procedures in future studies of gene function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18552341     DOI: 10.1093/jac/dkn245

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  24 in total

1.  Antifungal activity of Lactobacillus against Microsporum canis, Microsporum gypseum and Epidermophyton floccosum.

Authors:  Jiahui Guo; Brid Brosnan; Ambrose Furey; Elke Arendt; Padraigin Murphy; Aidan Coffey
Journal:  Bioeng Bugs       Date:  2012-03-01

2.  Evaluation of Antifungal Effect of Silver Nanoparticles Against Microsporum canis, Trichophyton mentagrophytes and Microsporum gypseum.

Authors:  Seyyed Amin Ayatollahi Mousavi; Samira Salari; Sanaz Hadizadeh
Journal:  Iran J Biotechnol       Date:  2015-12       Impact factor: 1.671

3.  Anti-fungal activity of Ctn[15-34], the C-terminal peptide fragment of crotalicidin, a rattlesnake venom gland cathelicidin.

Authors:  Carolina Sidrim P Cavalcante; Cláudio B Falcão; Raquel Os Fontenelle; David Andreu; Gandhi Rádis-Baptista
Journal:  J Antibiot (Tokyo)       Date:  2016-11-23       Impact factor: 2.649

4.  In vitro and in vivo assessment of dermatophyte acquired resistance to efinaconazole, a novel triazole antifungal.

Authors:  Atsushi Iwata; Yoko Watanabe; Naomichi Kumagai; Maria Katafuchi-Nagashima; Keita Sugiura; Radhakrishnan Pillai; Yoshiyuki Tatsumi
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

5.  Sequenced dermatophyte strains: growth rate, conidiation, drug susceptibilities, and virulence in an invertebrate model.

Authors:  Rebecca R Achterman; Adam R Smith; Brian G Oliver; Theodore C White
Journal:  Fungal Genet Biol       Date:  2010-12-07       Impact factor: 3.495

6.  Evaluation of Topical Antifungals Using a New Predictive Animal Model for Efficacy against Severe Tinea Unguium: A Comparison of Efinaconazole and Luliconazole.

Authors:  Akane Masumoto; Keita Sugiura; Yoshiki Matsuda; Haruki Tachibana; Yoshiyuki Tatsumi
Journal:  Mycopathologia       Date:  2022-09-12       Impact factor: 3.785

7.  Synergistic Effects of Efflux Pump Modulators on the Azole Antifungal Susceptibility of Microsporum canis.

Authors:  Chioma Inyang Aneke; Wafa Rhimi; Domenico Otranto; Claudia Cafarchia
Journal:  Mycopathologia       Date:  2020-01-01       Impact factor: 2.574

8.  Dermatophyte virulence factors: identifying and analyzing genes that may contribute to chronic or acute skin infections.

Authors:  Rebecca Rashid Achterman; Theodore C White
Journal:  Int J Microbiol       Date:  2011-10-04

9.  Update on terbinafine with a focus on dermatophytoses.

Authors:  Jason G Newland; Susan M Abdel-Rahman
Journal:  Clin Cosmet Investig Dermatol       Date:  2009-04-21

10.  In-vitro Activity of 10 Antifungal Agents against 320 Dermatophyte Strains Using Microdilution Method in Tehran.

Authors:  Parvaneh Adimi; Seyed Jamal Hashemi; Mahmood Mahmoudi; Hossein Mirhendi; Mohammad Reza Shidfar; Masood Emmami; Ali Rezaei-Matehkolaei; Mohsen Gramishoar; Parivash Kordbacheh
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.